Global Self-Monitoring Blood Glucose Strips Market Size By Type (Glucose Oxidase, Glucose Dehydrogenase), By Application (Hospital, Clinic), By Region, And Segment Forecasts, 2023 to 2032

The Global Self-Monitoring Blood Glucose (SMBG) Strips Market was valued at USD 9.2 billion in 2023 and is projected to reach USD 14.7 billion by 2031, growing at a CAGR of 6.1% during the forecast period from 2023 to 2031. This growth is primarily driven by the increasing prevalence of diabetes globally, growing awareness around self-health monitoring, and the continuous advancements in strip accuracy and user-friendliness. The market benefits significantly from the rise in home-based healthcare and personalized diabetes management strategies.

Drivers:

1. Rising Diabetes Incidence:

The increasing number of diabetic patients, particularly in emerging economies, is significantly boosting the demand for SMBG strips, which allow individuals to monitor their blood glucose levels regularly and conveniently.

2. Growth in Geriatric Population:

With a rising elderly population globally, the risk of type 2 diabetes and the need for self-monitoring tools like glucose strips are increasing steadily.

3. Technological Advancements in Testing Strips:

Ongoing R&D has resulted in the development of strips that require smaller blood samples, offer faster results, and are integrated with digital health monitoring apps, enhancing usability and compliance.

Restraints:

1. Reimbursement Limitations in Developing Economies:

In several lower-income regions, SMBG strips are not fully covered under health reimbursement schemes, limiting affordability for regular monitoring.

2. Competition from Continuous Glucose Monitoring (CGM) Systems:

The growing preference for CGM devices, which offer real-time blood sugar tracking, poses a competitive challenge to the SMBG strips market, particularly among tech-savvy and affluent patients.

Opportunity:

1. Expansion in Untapped Rural Markets:

With increasing healthcare outreach in rural areas and public health programs promoting diabetes care, the market has strong potential for growth in developing countries.

2. Integration with Mobile Health Applications:

SMBG strips compatible with smartphone apps are creating new opportunities for enhanced disease management and data-driven personalized healthcare, especially in younger populations.

Market by System Type Insights:

Based on system type, glucose oxidase-based strips held the dominant market share in 2023. Their popularity stems from affordability, ease of use, and compatibility with a wide range of glucometers. Meanwhile, glucose dehydrogenase-based strips are gaining traction due to their higher accuracy and reduced susceptibility to interferences, positioning them as a fast-growing segment during the forecast period.

Market by End-use Insights:

By end-use, the homecare segment accounted for the largest revenue share in 2023, supported by the global trend of managing chronic conditions from home. This is followed by hospital and diagnostic laboratories, which continue to utilize SMBG strips for rapid bedside glucose assessments and initial diagnostics.

Market by Regional Insights:

North America led the market in 2023, attributed to a high diabetic population, favorable reimbursement structures, and early adoption of home-based diagnostic tools. Asia-Pacific is expected to witness the highest growth rate through 2031, driven by expanding healthcare infrastructure, increasing diabetic population, and growing awareness regarding diabetes management.

Competitive Scenario:

Prominent players in the global SMBG strips market include Roche Diagnostics, Abbott Laboratories, Ascensia Diabetes Care, LifeScan Inc., ARKRAY, Inc., and B. Braun Melsungen AG. Companies are focusing on product innovation, strategic distribution partnerships, and geographic expansion to strengthen market share.

Key Market Developments:

In 2023, Abbott Laboratories launched an upgraded line of SMBG strips featuring improved enzyme stability for high-altitude and humid environments.

In 2024, Roche Diagnostics introduced an integrated app feature that allows users to sync blood glucose data directly with their physician’s electronic health record (EHR) systems.

In 2025, Ascensia Diabetes Care partnered with a telemedicine provider to distribute SMBG kits with remote consultation services in Southeast Asia.

Scope of Work – Global Self-Monitoring Blood Glucose Strips Market

Report Metric Details

Market Size (2023) USD 9.2 billion

Projected Market Size (2031) USD 14.7 billion

CAGR (2023-2031) 6.1%

Key Segments by System Type Glucose Oxidase-based, Glucose Dehydrogenase-based

Key Segments by End-Use Homecare, Hospitals, Diagnostic Laboratories

Leading Region North America

Key Players Roche, Abbott, Ascensia, LifeScan, ARKRAY

Growth Drivers Rising diabetes cases, tech innovation

Opportunities mHealth integration, rural market penetration

FAQs:

1) What is the current market size of the Global Self-Monitoring Blood Glucose Strips Market?

The market size was USD 9.2 billion in 2023.

2) What is the major growth driver of the Global Self-Monitoring Blood Glucose Strips Market?

The primary driver is the increasing prevalence of diabetes and growing demand for home-based glucose monitoring tools.

3) Which is the largest region during the forecast period in the Global Self-Monitoring Blood Glucose Strips Market?

North America is projected to remain the largest market region.

4) Which segment accounted for the largest market share in the Global Self-Monitoring Blood Glucose Strips Market?

The homecare segment held the largest share in 2023.

5) Who are the key market players in the Global Self-Monitoring Blood Glucose Strips Market?

Key players include Roche Diagnostics, Abbott Laboratories, Ascensia Diabetes Care, LifeScan Inc., and ARKRAY, Inc.

Would you like a visual chart or infographic summary to accompany this report description?